drugset / Trial / NCT03772938
Stem Cells Therapy in Degenerative Diseases of the Retina
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to test the safety and effectiveness of an autologous bone marrow-derived stem/progenitor cells administered intravitreously in the subjects with degenerative diseases of the retina.
Timeline
- Start
- 2018-12-13
- Primary completion
- 2020-02-28
- Completion
- 2020-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Stem/progenitor cells transplantation | Cell therapy | — | Intravitreal |